Source comparison

KPV Crohn's Support Results Timeline Expect: Comparison by Severity and Route

Mild Crohn's (CDAI <220) First-line option. Faster onset, lower dose Viable alternative if injections aren't feasible 2–3 weeks for noticeable improvement 8–10 weeks on endoscopy Subcutaneous preferred for speed; oral acceptable if compliance with higher dosin

This comparison does not assign a generated winner or score.

Mild Crohn's (CDAI <220)
First-line option. Faster onset, lower dose
Viable alternative if injections aren't feasible
2–3 weeks for noticeable improvement
8–10 weeks on endoscopy
Subcutaneous preferred for speed; oral acceptable if compliance with higher dosing is reliable
Moderate Crohn's (CDAI 220–450)
Preferred. Higher bioavailability critical for inflammatory burden
Requires higher doses and patience. Slower onset
3–4 weeks for partial response, 6–8 weeks for significant improvement
10–12 weeks minimum
Subcutaneous strongly recommended. Oral may underdose at standard ranges
Severe Crohn's (CDAI >450)
Adjunct only. Biologics or immunosuppressants remain primary therapy
Not recommended as monotherapy
Variable. Often used alongside biologics to reduce steroid dependence
12+ weeks if combined with standard therapy
KPV is not a replacement for biologics in severe disease. It's a complementary anti-inflammatory tool